Association between nonsteroidal anti-inflammatory drugs and prostate cancer occurrence

K Dasgupta, D Di Cesar, J Ghosn, R Rajan… - The Cancer …, 2006 - journals.lww.com
Prostate cancer is the most common malignancy among men in Western nations. Previous
studies indicate that non-steroidal anti-inflammatory drugs have an inhibitory effect on …

Cyclooxygenase-2 expression in human colorectal cancer is unrelated to overall patient survival

R Fux, M Schwab, KP Thon, CH Gleiter, P Fritz - Clinical cancer research, 2005 - AACR
Abstract Purpose: Cyclooxygenase-2 (COX-2) expression in human colorectal cancer and
adenoma tissue seems to be higher than in normal mucosa. However, data about the …

Hospitalization for gastrointestinal bleeding associated with non-steroidal anti-inflammatory drugs among elderly patients using low-dose aspirin: a retrospective …

E Rahme, M Bardou, K Dasgupta, Y Toubouti… - …, 2007 - academic.oup.com
Objectives. Many elderly patients are prescribed both low-dose aspirin (ASA), for
cardiovascular protection and non-steroidal anti-inflammatory drugs (NSAIDs) for pain …

In vitro and in vivo evaluation of guar gum-based matrix tablets of rofecoxib for colonic drug delivery

SM Al-Saidan, YSR Krishnaiah… - Current Drug …, 2005 - ingentaconnect.com
The present study was carried out to develop and evaluate guar gum-based matrix tablets of
rofecoxib for their intended use in the chemoprevention of colorectal cancer. Matrix tablets …

[HTML][HTML] Role of gastrin-peptides in Barrett's and colorectal carcinogenesis

E Chueca, A Lanas, E Piazuelo - World Journal of …, 2012 - ncbi.nlm.nih.gov
Gastrin is the main hormone responsible for the stimulation of gastric acid secretion; in
addition, gastrin and its derivatives exert proliferative and antiapoptotic effects on several …

The association between Charlson comorbidity index and the medical care cost of cancer: a retrospective study

SJ Yoon, EJ Kim, HJ Seo, IH Oh - BioMed research …, 2015 - Wiley Online Library
Background. This study compared comorbidity‐related medical care cost associated with
different types of cancer, by examining breast (N= 287), colon (N= 272), stomach (N= 614) …

Preparation and characterization of celecoxib entrapped guar gum nanoparticles targeted for oral drug delivery against colon cancer: an in-vitro study

D Chandel, S Uppal, SK Mehta… - Journal of Drug Delivery …, 2020 - jddtonline.info
The present study is an attempt to synthesize nanosized guar gum carriers encapsulating
celecoxib as the chemopreventive agent for experimental colorectal cancer (CRC). Guar …

The effect of celecoxib and its combination with imatinib on human HT-29 colorectal cancer cells: Involvement of COX-2, Caspase-3, VEGF and NF-κB genes …

S Atari-Hajipirloo, S Nikanfar, A Heydari… - Cellular and Molecular …, 2016 - cellmolbiol.org
It has been shown that combination of imatinib (IM) with other agents may have some
advantages in avoiding toxicity and resistance caused by this drug. The selective …

Chemoprevention of colorectal cancer: ready for routine use?

N Arber, B Levin - Current Topics in Medicinal Chemistry, 2005 - ingentaconnect.com
In the third millennium preventive medicine is becoming a corner stone in our concept of
health. Colorectal cancer (CRC) prevention, in particular, has become an important goal for …

Effect of celecoxib on restenosis after coronary angioplasty with a Taxus stent (COREA-TAXUS trial): an open-label randomised controlled study

BK Koo, YS Kim, KW Park, HM Yang, DA Kwon… - The Lancet, 2007 - thelancet.com
Background In-vitro and animal experiments have shown that the cyclo-oxygenase 2
inhibitor celecoxib can reduce formation of neointima within stents. We aimed to test whether …